This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benaissa-Trouw, B.
Right arrow Articles by Snippe, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benaissa-Trouw, B.
Right arrow Articles by Snippe, H.

 Previous Article  |  Next Article 

Infection and Immunity, July 2001, p. 4698-4701, Vol. 69, No. 7
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.7.4698-4701.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Synthetic Polysaccharide Type 3-Related Di-, Tri-, and Tetrasaccharide-CRM197 Conjugates Induce Protection against Streptococcus pneumoniae Type 3 in Mice

Barry Benaissa-Trouw,1,* Dirk J. Lefeber,2 Johannis P. Kamerling,2 Johannes F. G. Vliegenthart,2 Kees Kraaijeveld,1 and Harm Snippe1

Vaccines Section, Eijkman-Winkler Institute for Microbiology, Infectious Diseases and Inflammation, Utrecht Medical Center,2 and Bijvoet Center, Department of Bio-Organic Chemistry, Utrecht University,1 Utrecht, The Netherlands

Received 3 November 2000/Returned for modification 6 December 2000/Accepted 29 March 2001

Di-, tri-, and tetrasaccharides, synthesized according to the chemical structure of pneumococcal polysaccharide type 3 (PS3), were coupled to the cross-reactive material (CRM197) of modified diphtheria toxin in different molar carbohydrate/protein ratios using the squarate coupling method. To study protective immunity, female BALB/c mice were subcutaneously immunized twice (with a 3-week interval) using the amount of conjugates corresponding to 2.5 µg of oligosaccharide per mouse. The conjugates evoked PS3 binding immunoglobulin G antibodies that lasted for at least 7 weeks after the booster. Immunogenicity was not influenced by the carbohydrate/protein ratio. All mice with PS3-specific antibodies survived the intraperitoneal challenge with Streptococcus pneumoniae type 3. Therefore, synthetic oligosaccharide-protein conjugates might have potential as vaccines.


* Corresponding author. Mailing address: Eijkman-Winkler Institute for Microbiology, Infectious Diseases and Inflammation, Vaccines Section, Utrecht Medical Center, HP G 04.614, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Phone: 31-30-2507635. Fax: 31-30-2541770. E-mail: B.J.BenaissaTrouw{at}lab.azu.nl.


Infection and Immunity, July 2001, p. 4698-4701, Vol. 69, No. 7
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.7.4698-4701.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Park, S., Parameswar, A. R., Demchenko, A. V., Nahm, M. H. (2009). Identification of a Simple Chemical Structure Associated with Protective Human Antibodies against Multiple Pneumococcal Serogroups. Infect. Immun. 77: 3374-3379 [Abstract] [Full Text]  
  • Phalipon, A., Tanguy, M., Grandjean, C., Guerreiro, C., Belot, F., Cohen, D., Sansonetti, P. J., Mulard, L. A. (2009). A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Shigella flexneri 2a Infection. J. Immunol. 182: 2241-2247 [Abstract] [Full Text]  
  • Safari, D., Dekker, H. A. T., Joosten, J. A. F., Michalik, D., de Souza, A. C., Adamo, R., Lahmann, M., Sundgren, A., Oscarson, S., Kamerling, J. P., Snippe, H. (2008). Identification of the Smallest Structure Capable of Evoking Opsonophagocytic Antibodies against Streptococcus pneumoniae Type 14. Infect. Immun. 76: 4615-4623 [Abstract] [Full Text]  
  • Vulliez-Le Normand, B., Saul, F. A., Phalipon, A., Belot, F., Guerreiro, C., Mulard, L. A., Bentley, G. A. (2008). Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody. Proc. Natl. Acad. Sci. USA 105: 9976-9981 [Abstract] [Full Text]  
  • Phalipon, A., Costachel, C., Grandjean, C., Thuizat, A., Guerreiro, C., Tanguy, M., Nato, F., Vulliez-Le Normand, B., Belot, F., Wright, K., Marcel-Peyre, V., Sansonetti, P. J., Mulard, L. A. (2006). Characterization of Functional Oligosaccharide Mimics of the Shigella flexneri Serotype 2a O-Antigen: Implications for the Development of a Chemically Defined Glycoconjugate Vaccine. J. Immunol. 176: 1686-1694 [Abstract] [Full Text]  
  • Michon, F., Moore, S. L., Kim, J., Blake, M. S., Auzanneau, F.-I., Johnston, B. D., Johnson, M. A., Pinto, B. M. (2005). Doubly Branched Hexasaccharide Epitope on the Cell Wall Polysaccharide of Group A Streptococci Recognized by Human and Rabbit Antisera. Infect. Immun. 73: 6383-6389 [Abstract] [Full Text]  
  • Meeks, M. D., Saksena, R., Ma, X., Wade, T. K., Taylor, R. K., Kovac, P., Wade, W. F. (2004). Synthetic Fragments of Vibrio cholerae O1 Inaba O-Specific Polysaccharide Bound to a Protein Carrier Are Immunogenic in Mice but Do Not Induce Protective Antibodies. Infect. Immun. 72: 4090-4101 [Abstract] [Full Text]  
  • Lefeber, D. J., Benaissa-Trouw, B., Vliegenthart, J. F. G., Kamerling, J. P., Jansen, W. T. M., Kraaijeveld, K., Snippe, H. (2003). Th1-Directing Adjuvants Increase the Immunogenicity of Oligosaccharide-Protein Conjugate Vaccines Related to Streptococcus pneumoniae Type 3. Infect. Immun. 71: 6915-6920 [Abstract] [Full Text]  
  • Mawas, F., Niggemann, J., Jones, C., Corbel, M. J., Kamerling, J. P., Vliegenthart, J. F. G. (2002). Immunogenicity in a Mouse Model of a Conjugate Vaccine Made with a Synthetic Single Repeating Unit of Type 14 Pneumococcal Polysaccharide Coupled to CRM197. Infect. Immun. 70: 5107-5114 [Abstract] [Full Text]